Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × MK 2206 × Clear all

NCT01283035 2016-06-24

A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer

Phase 2 Completed

6 enrolled 7 charts

Fallopian Tube Neoplasms, Ovarian Neoplasms